Alere

315 articles about Alere

• Alere Announces Commencement Of Consent Solicitations For Alere Inc.'s Notes

  4/29/2016

• Abbott's $25 Billion Bid for St. Jude Medical Raises Questions About Pending Alere Deal

  4/28/2016

• Alere Received Notice of Default from Group of Bondholders

  4/26/2016

• Alere Stock Falls as Abbott CEO Declines to Comment and Confirm $6 Billion Deal

  4/22/2016

• Alere Receives NYSE Notice Regarding Late Form 10-K Filing

  3/22/2016

• Alere Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock

  3/18/2016

• Alere Comments On Alere Anticoagulation Monitoring Technology

  3/18/2016

• U.S. DoJ Seeks Documents Regarding Sales Practices from Alere

  3/15/2016

• Newly-Acquired Alere to Create 40 New Jobs in Ireland

  2/29/2016

• Alere To Report Fourth Quarter And Full Year 2015 Financial Results On February 26, 2016

  2/22/2016

• Drugmaker Abbott Snaps Up Alere for $5.8 Billion

  2/2/2016

• Amid Biotech Bloodbath, Investors Turn Their Eyes Onto Alere at J.P. Morgan

  1/12/2016

• Alere To Present At 34th Annual J.P. Morgan Healthcare Conference

  1/7/2016

• Alere Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock

  12/15/2015

• Response Biomedical Announces Strategic Alliances In Japan With Alere And Long Time Partner Shionogi

  12/9/2015

• Alere Completes Divestiture Of BBI Group

  11/19/2015

• Alere's SD BIOLINE HIV/Syphilis Duo Is First Dual Test To Receive WHO Prequalification

  11/9/2015

• Alere Reports Third Quarter 2015 Financial Results

  11/5/2015

• Alere To Report Third Quarter 2015 Financial Results On November 4, 2015

  10/28/2015

• Alere Receives U.S. HHS Approval To Electronically Process Drug Tests For Department Of Transportation-Regulated Employees

  10/15/2015